Shuttle Pharmaceuticals Holdings, Inc.(SHPH)
Life Sciences Tools & Services
Clinical Trial Software & Data
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-15 | HRT FINANCIAL LP 10% Owner | Sale | -83,149 | -100.00%0 | $4.48 | $372,704 | View SEC filing | |
| 2026-07-13 | HRT FINANCIAL LP 10% Owner | Purchase | +8,997 | +17.21%61,271 | $3.36 | $30,212 | View SEC filing | |
| 2026-07-09 | HRT FINANCIAL LP 10% Owner | Sale | -29,111 | -35.77%52,274 | $3.45 | $100,461 | View SEC filing | |
| 2026-07-07 | HRT FINANCIAL LP 10% Owner | Mixed | -1,171 | -1.42%81,385 | $3.52 | $59,460 | View SEC filing | |
| 2026-07-02 | HRT FINANCIAL LP 10% Owner | Purchase | +3,959 | +5.04%82,556 | $3.30 | $13,065 | View SEC filing | |
| 2026-07-01 | HRT FINANCIAL LP 10% Owner | Purchase | +32,591 | +70.84%78,597 | $3.40 | $110,694 | View SEC filing | |
| 2024-03-14 | Senanayake Chris Director | Sale | -1,626 | -36.81%2,791 | $1.60 | $2,610 | View SEC filing | |
| 2024-01-02 | Brown Milton Director | Sale | -2,921 | -0.27%1,094,610 | $0.46 | $1,353 | View SEC filing | |
| 2023-12-20 | Jacobs Bette Director | Sale | -4,157 | -6.66%58,285 | $0.46 | $1,926 | View SEC filing | |
| 2023-01-09 | Richards Steven M Director | Sale | -995 | -36.82%1,707 | $1.60 | $1,597 | View SEC filing | |
| 2023-01-04 | Adkins William Other | Sale | -995 | -0.54%184,071 | $1.60 | $1,597 | View SEC filing | |
| 2023-01-04 | Brown Milton Director | Sale | -995 | -0.09%1,072,531 | $1.60 | $1,597 | View SEC filing | |
| 2023-01-03 | Dritschilo Anatoly CEO and Chairman | Sale | -8,372 | -0.77%1,085,200 | $1.60 | $13,437 | View SEC filing | |
| 2023-01-03 | Rich Tyvin Chief Medical Officer | Sale | -1,414 | -36.79%2,429 | $1.60 | $2,269 | View SEC filing | |
| 2023-01-03 | Jung Mira Chief Scientific Officer | Sale | -328 | -0.02%2,143,104 | $1.61 | $526 | View SEC filing | |
| 2023-01-03 | Jacobs Bette Director | Sale | -4,366 | -12.27%31,221 | $1.60 | $7,007 | View SEC filing | |
| 2022-12-30 | Dritschilo Peter President and COO | Sale | -3,820 | -36.80%6,560 | $1.61 | $6,131 | View SEC filing | |
| 2022-12-30 | Vander Hoek Michael Chief Financial Officer | Sale | -2,243 | -36.80%3,852 | $1.60 | $3,600 | View SEC filing |
1-18 of 18